8 results
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
Vasculitis Management - ACR ... Guidelines for Treatment ... • Giant Cell Arteritis ... #ACR2021 #Guidelines ... #algorithm #rheumatology
2021 ACR/VF Guidelines for Management of Takayasu Arteritis (TAK)

#Takayasu #Arteritis #TAK #ACR2021 #Management #rheumatology #algorithm #vasculitis
2021 ACR/VF Guidelines ... #Arteritis #TAK ... #ACR2021 #Management ... #rheumatology # ... algorithm #vasculitis
Takayasu's Arteritis (TAK) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active TAK not on
Takayasu's Arteritis ... - ACR/VF 2021 Guidelines ... Vasculitis #Management #Treatment ... #ACR2021 #Guidelines ... #algorithm #rheumatology
Giant Cell Arteritis (GCA) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Visual Symptoms/Loss or
Giant Cell Arteritis ... - ACR/VF 2021 Guidelines ... Vasculitis #Management #Treatment ... #ACR2021 #Guidelines ... #algorithm #rheumatology
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
Constitutional symptoms, Arthritis ... • Immunologic Workup ... • Immunologic Workup ... life-threatening • Treatment ... #diagnosis #management
There are similarities and differences between these 3 conditions which all carry treatment implications. Each mimic
carry treatment ... hormones that work ... #diagnosis #differential ... #algorithm #management ... #treatment #criticalcare
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
that affect the JAK-STAT ... Splenomegaly Diagnosis ... • Treatment algorithms ... Thrombocythemia #ET #hematology ... #hematology
Drug Induced Lupus (DIL)
 • Epidemiology: -10% of all lupus cases, drug-dependent, 4:1 to 1:1 F:M
Constitutional symptoms, Arthritis ... • Immunologic Workup ... constitutional symptoms • Treatment ... DrugInduced #Lupus #DIL #rheumatology ... #diagnosis #treatment